11-71444107-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001360.3(DHCR7):ā€‹c.207T>Cā€‹(p.Thr69=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.924 in 1,612,316 control chromosomes in the GnomAD database, including 693,393 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.90 ( 61539 hom., cov: 33)
Exomes š‘“: 0.93 ( 631854 hom. )

Consequence

DHCR7
NM_001360.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -3.42
Variant links:
Genes affected
DHCR7 (HGNC:2860): (7-dehydrocholesterol reductase) This gene encodes an enzyme that removes the C(7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to cholesterol. This gene is ubiquitously expressed and its transmembrane protein localizes to the endoplasmic reticulum membrane and nuclear outer membrane. Mutations in this gene cause Smith-Lemli-Opitz syndrome (SLOS); a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by cognitive disability, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. Alternative splicing results in multiple transcript variants that encode the same protein.[provided by RefSeq, Aug 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 11-71444107-A-G is Benign according to our data. Variant chr11-71444107-A-G is described in ClinVar as [Benign]. Clinvar id is 93715.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-71444107-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.95 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DHCR7NM_001360.3 linkuse as main transcriptc.207T>C p.Thr69= synonymous_variant 4/9 ENST00000355527.8
DHCR7NM_001163817.2 linkuse as main transcriptc.207T>C p.Thr69= synonymous_variant 4/9
DHCR7XM_011544777.3 linkuse as main transcriptc.207T>C p.Thr69= synonymous_variant 4/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DHCR7ENST00000355527.8 linkuse as main transcriptc.207T>C p.Thr69= synonymous_variant 4/91 NM_001360.3 P1

Frequencies

GnomAD3 genomes
AF:
0.896
AC:
136326
AN:
152110
Hom.:
61508
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.839
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.846
Gnomad ASJ
AF:
0.839
Gnomad EAS
AF:
0.842
Gnomad SAS
AF:
0.679
Gnomad FIN
AF:
0.946
Gnomad MID
AF:
0.835
Gnomad NFE
AF:
0.956
Gnomad OTH
AF:
0.896
GnomAD3 exomes
AF:
0.872
AC:
215917
AN:
247586
Hom.:
95461
AF XY:
0.870
AC XY:
116512
AN XY:
133990
show subpopulations
Gnomad AFR exome
AF:
0.837
Gnomad AMR exome
AF:
0.771
Gnomad ASJ exome
AF:
0.850
Gnomad EAS exome
AF:
0.849
Gnomad SAS exome
AF:
0.681
Gnomad FIN exome
AF:
0.946
Gnomad NFE exome
AF:
0.950
Gnomad OTH exome
AF:
0.888
GnomAD4 exome
AF:
0.927
AC:
1353425
AN:
1460088
Hom.:
631854
Cov.:
56
AF XY:
0.921
AC XY:
668479
AN XY:
726190
show subpopulations
Gnomad4 AFR exome
AF:
0.829
Gnomad4 AMR exome
AF:
0.778
Gnomad4 ASJ exome
AF:
0.849
Gnomad4 EAS exome
AF:
0.868
Gnomad4 SAS exome
AF:
0.688
Gnomad4 FIN exome
AF:
0.945
Gnomad4 NFE exome
AF:
0.959
Gnomad4 OTH exome
AF:
0.901
GnomAD4 genome
AF:
0.896
AC:
136408
AN:
152228
Hom.:
61539
Cov.:
33
AF XY:
0.892
AC XY:
66388
AN XY:
74408
show subpopulations
Gnomad4 AFR
AF:
0.839
Gnomad4 AMR
AF:
0.845
Gnomad4 ASJ
AF:
0.839
Gnomad4 EAS
AF:
0.843
Gnomad4 SAS
AF:
0.679
Gnomad4 FIN
AF:
0.946
Gnomad4 NFE
AF:
0.956
Gnomad4 OTH
AF:
0.894
Alfa
AF:
0.929
Hom.:
76147
Bravo
AF:
0.888
Asia WGS
AF:
0.706
AC:
2456
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Smith-Lemli-Opitz syndrome Benign:6
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 08, 2017- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 05, 2021- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
Benign, no assertion criteria providedclinical testingNatera, Inc.May 05, 2017- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
not specified Benign:5
Benign, criteria provided, single submitterclinical testingGeneDxDec 16, 2015This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 06, 2018- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 11, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.061
DANN
Benign
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1790334; hg19: chr11-71155153; COSMIC: COSV62796119; COSMIC: COSV62796119; API